Drug Profile
Research programme: GPCR targeting therapeutics - Nxera Pharma/Imperial College of Science Technology and Medicine
Alternative Names: G protein-coupled modulators - Imperial College of Science Technology and Medicine/Nxera Pharma; G protein-coupled modulators - Nxera Pharma/Imperial College of Science Technology and Medicine; GPCR targeting therapeutics - Imperial College of Science Technology and Medicine/Nxera PharmaLatest Information Update: 02 Apr 2024
Price :
$50
*
At a glance
- Originator Heptares Therapeutics; Imperial College of Science, Technology and Medicine
- Developer Imperial College of Science, Technology and Medicine; Nxera Pharma
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastrointestinal disorders